190 related articles for article (PubMed ID: 2843003)
1. Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity.
Murray E; Provvedini D; Curran D; Catherwood B; Sussman H; Manolagas S
J Bone Miner Res; 1987 Jun; 2(3):231-8. PubMed ID: 2843003
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.
Rodan SB; Imai Y; Thiede MA; Wesolowski G; Thompson D; Bar-Shavit Z; Shull S; Mann K; Rodan GA
Cancer Res; 1987 Sep; 47(18):4961-6. PubMed ID: 3040234
[TBL] [Abstract][Full Text] [Related]
4. Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation.
Fohr B; Schulz A; Battmann A
Exp Clin Endocrinol Diabetes; 2000; 108(6):414-23. PubMed ID: 11026755
[TBL] [Abstract][Full Text] [Related]
5. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro.
Nakao Y; Hilliker S; Baylink DJ; Mohan S
J Bone Miner Res; 1994 Jun; 9(6):865-72. PubMed ID: 7521561
[TBL] [Abstract][Full Text] [Related]
6. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
[TBL] [Abstract][Full Text] [Related]
7. A newly established human osteosarcoma cell line with osteoblastic properties.
Kawai A
Clin Orthop Relat Res; 1990 Oct; (259):256-67. PubMed ID: 2170070
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a conditionally transformed adult human osteoblastic cell line.
Bodine PV; Trailsmith M; Komm BS
J Bone Miner Res; 1996 Jun; 11(6):806-19. PubMed ID: 8725178
[TBL] [Abstract][Full Text] [Related]
9. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
[TBL] [Abstract][Full Text] [Related]
10. Marrow stroma-derived osteogenic clonal cell lines: putative stages in osteoblastic differentiation.
Fried A; Benayahu D; Wientroub S
J Cell Physiol; 1993 Jun; 155(3):472-82. PubMed ID: 8388001
[TBL] [Abstract][Full Text] [Related]
11. Osteocalcin secretion by the human osteosarcoma cell line MG-63.
Lajeunesse D; Frondoza C; Schoffield B; Sacktor B
J Bone Miner Res; 1990 Sep; 5(9):915-22. PubMed ID: 2177953
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid-induced increase in these receptors: relationship to adenylate cyclase activation.
Titus L; Jackson E; Nanes MS; Rubin JE; Catherwood BD
J Bone Miner Res; 1991 Jun; 6(6):631-7. PubMed ID: 1653516
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells.
Bjurholm A; Kreicbergs A; Schultzberg M; Lerner UH
J Bone Miner Res; 1992 Sep; 7(9):1011-9. PubMed ID: 1384276
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.
Titus L; Rubin JE; Lorang MT; Catherwood BD
Endocrinology; 1988 Sep; 123(3):1526-34. PubMed ID: 2456915
[TBL] [Abstract][Full Text] [Related]
15. Dibutyryl cyclic adenosine monophosphate differentially regulates cell proliferation in low and high alkaline phosphatase SaOS-2 human osteosarcoma cells: evidence for mediation by the insulin-like growth factor-II system.
Mohan S; Strong DD; Hilliker S; Malpe R; Lee K; Farley J; Baylink DJ
J Cell Physiol; 1993 Sep; 156(3):462-8. PubMed ID: 7689570
[TBL] [Abstract][Full Text] [Related]
16. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2.
Farley JR; Hall SL; Herring S; Tarbaux NM; Matsuyama T; Wergedal JE
Metabolism; 1991 Jul; 40(7):664-71. PubMed ID: 1651438
[TBL] [Abstract][Full Text] [Related]
17. 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line.
Franceschi RT; James WM; Zerlauth G
J Cell Physiol; 1985 Jun; 123(3):401-9. PubMed ID: 2985632
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 and transforming growth factor-beta act synergistically to override extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells.
Johnson-Pais TL; Leach RJ
Exp Cell Res; 1996 Jul; 226(1):67-74. PubMed ID: 8682172
[TBL] [Abstract][Full Text] [Related]
19. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells.
Mulkins MA; Manolagas SC; Deftos LJ; Sussman HH
J Biol Chem; 1983 May; 258(10):6219-25. PubMed ID: 6189822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
